Press Releases by Category Health & Medicine
Cell Harvesting System Market to Reach US$ 15.5 Bn by 2032, Says Persistence Mar …
The global cell harvesting system market has emerged as a critical segment within the biopharmaceutical and regenerative medicine industry. Cell harvesting refers to the isolation of target cells from growth media, an essential step in biologic manufacturing, cell-based therapies, and regenerative medicine. Traditionally, this process relied heavily on manual techniques such as centrifugation and depth filtration, which often posed challenges in consistency, throughput, and scalability. However, with increasing automation and…
Veterinary Parasiticides Market Overview and Competitive Landscape - Persistence …
The veterinary parasiticides market has witnessed substantial growth over the past few years, driven by increasing pet ownership, a rise in livestock production, and growing awareness of animal health. Veterinary parasiticides refer to drugs designed to eliminate parasites, including endoparasites and ectoparasites, in both companion and production animals. These parasitic infections, if left untreated, can cause severe health issues, reduced productivity in livestock, and economic losses in the agriculture and…
Vagus Nerve Stimulation Market Size Projected at US$542.3 Mn in 2025, Growing at …
The global vagus nerve stimulation (VNS) market is witnessing unprecedented growth, driven by the rising prevalence of neurological disorders and expanding clinical applications. According to Persistence Market Research, the market size is projected to reach US$542.3 million in 2025 and is expected to surge to US$1,013.4 million by 2032, registering a CAGR of 9.3% from 2025 to 2032. This remarkable growth can be attributed to advancements in device technologies, growing…
Interventional Oncology Market Expansion and Opportunities Highlighted by Persis …
The interventional oncology market is experiencing rapid growth as healthcare systems worldwide increasingly adopt minimally invasive cancer treatment methods. Interventional oncology focuses on targeted therapies such as radiofrequency ablation, cryoablation, microwave ablation, and transarterial chemoembolization to treat tumors with precision while minimizing patient discomfort. The market is further benefiting from advancements in imaging technologies, including MRI and CT scans, which enhance procedural accuracy and outcomes. According to Persistence Market Research,…
Whole Genome Sequencing Market Analysis and Trends Report by Persistence Market …
Whole Genome Sequencing (WGS) is transforming the landscape of genomics research, clinical diagnostics, and personalized medicine. It involves decoding an organism's entire genetic blueprint, providing comprehensive insights into genetic variants, mutations, and hereditary conditions. WGS allows scientists and clinicians to analyze the entire DNA sequence of an individual, uncovering rare genetic disorders, assessing disease risks, and guiding precision therapies. The growing adoption of WGS across healthcare, research, and biotechnology sectors…
Transcatheter Aortic Valve Replacement Market Analysis and Trends - Persistence …
The Transcatheter Aortic Valve Replacement (TAVR) market has emerged as a transformative segment within the cardiovascular healthcare industry. Offering a minimally invasive alternative to conventional open-heart surgery, TAVR is particularly significant for patients at high or intermediate surgical risk. Persistence Market Research reports that the market was valued at US$5.64 billion in 2024 and is expected to reach US$10.5 billion by 2031, growing at a CAGR of 6.5% over the…
Breast Lesion Localization Methods Market Insights by Persistence Market Researc …
The global breast lesion localization methods market is projected to witness substantial growth, driven by the increasing prevalence of breast cancer and the rising demand for minimally invasive procedures. According to Persistence Market Research, the market is expected to grow from US$2.52 Bn in 2024 to US$6.8 Bn by 2031, achieving a CAGR of 5.7% during the forecast period. The growing adoption of innovative localization techniques such as magnetic seed…
Continuous Renal Replacement Therapy Market Forecasted to Hit US$ 4.6 Billion by …
The global continuous renal replacement therapy (CRRT) market is experiencing rapid growth, fueled by the rising incidence of acute kidney injury (AKI) and the increasing need for advanced critical care solutions. According to Persistence Market Research, the global CRRT market is projected to expand from US$ 2.6 Bn in 2025 to US$ 4.6 Bn by 2032, reflecting a robust CAGR of 8.5% during the forecast period. This growth highlights CRRT's…
Acute Liver Failure Treatment Market Valued at US$ 1.8 Bn in 2025, Set to Grow R …
The global acute liver failure (ALF) treatment market is entering a period of strong growth, shaped by medical advancements and rising healthcare awareness. According to estimates, the market is projected to reach a valuation of US$ 1.8 billion in 2025 and grow further to US$ 3.0 billion by 2032, expanding at a healthy CAGR of 7.8%. Factors such as the increasing prevalence of hepatitis-related cases, alcohol-related liver disease, and drug-induced…
Molecular Diagnostics Market Projected to Grow from US$25.2 Billion in 2025 to U …
The molecular diagnostics market is at the forefront of transforming modern healthcare. With the ability to identify diseases at a genetic level, molecular diagnostics offers unparalleled accuracy in detecting infectious diseases, cancers, and genetic disorders. According to Persistence Market Research, the global molecular diagnostics market is projected to grow from US$ 25.2 billion in 2025 to US$ 43.4 billion by 2032, expanding at a steady CAGR of 8.1%. This reflects…
Breath Analyzer Market Is Anticipated To Expand From $4.1 Billion In 2024 To $9. …
Market Overview
The Breath Analyzer Market is gaining remarkable traction worldwide as demand for alcohol detection and health monitoring tools continues to rise. These devices, designed to measure blood alcohol content (BAC) through breath samples, have become indispensable in law enforcement, healthcare, and workplace safety. The market is projected to expand from $4.1 billion in 2024 to $9.8 billion by 2034, growing at a CAGR of 9.1%. This growth is fueled…
Oral Solid Dosage Pharmaceutical Formulation Market Expected to Reach USD 1,349. …
Opening Paragraph
According to a new report by Maximize Market Research, the global Oral Solid Dosage Pharmaceutical Formulation Market was valued at USD 779.44 billion in 2024 and is projected to reach USD 1,349.27 billion by 2032, growing at a CAGR of 7.1% between 2025 and 2032
Download your sample copy of this report today! https://www.maximizemarketresearch.com/request-sample/121388/
Key Highlights
Market Size & CAGR: USD 779.44 billion in 2024; projected…
Spinocerebellar Ataxias Pipeline 2025: Comprehensive Clinical Trials and Therapi …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spinocerebellar Ataxias pipeline constitutes 8+ key companies continuously working towards developing 10+ Spinocerebellar Ataxias treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Spinocerebellar Ataxias Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Spinocerebellar Ataxias Market.
The Spinocerebellar…
Presbyopia Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight O …
The Presbyopia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Presbyopia pipeline products will significantly revolutionize the Presbyopia market dynamics.
DelveInsight's "Presbyopia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Presbyopia, historical and forecasted epidemiology as well as the Presbyopia market trends in the United States, EU5 (Germany, Spain, Italy, France,…
Idiopathic Pulmonary Fibrosis Market Insights Highlight Expanding Outlook Till 2 …
DelveInsight's "Idiopathic Pulmonary Fibrosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Idiopathic Pulmonary Fibrosis, historical and forecasted epidemiology as well as the Idiopathic Pulmonary Fibrosis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Idiopathic Pulmonary Fibrosis, offering comprehensive insights into the Idiopathic Pulmonary Fibrosis revenue trends,…
Myocardial Infarction Market Positioned for Accelerated Development Through 2034 …
DelveInsight's "Myocardial Infarction Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Myocardial Infarction market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Myocardial Infarction Market Forecast
https://www.delveinsight.com/sample-request/myocardial-infarction-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Intrahepatic Cholangiocarcinoma Pipeline 2025: Latest FDA Approvals, Clinical Tr …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Intrahepatic Cholangiocarcinoma pipeline constitutes 18+ key companies continuously working towards developing 20+ Intrahepatic Cholangiocarcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Intrahepatic Cholangiocarcinoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report…
GLP-1 Analogues Market Forecast: USD 471.1 Billion by 2032
The report "GLP-1 Analogues Market by Product (Ozempic, Rybelsus, Saxenda, Wegovy, Mounjaro, Zepbound, Victoza, Trulicity), Format (Single dose, Multi-dose, Tablets), ROA (Subcutaneous, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2032", is projected to reach USD 471.1 billion by 2032 from USD 47.4 billion in 2024, at a CAGR of 33.2% during the forecast period
The global GLP-1 analogues market [https://www.marketsandmarkets.com/Market-Reports/glp-1-analogues-market-218746186.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is poised for substantial growth, projected to expand from USD…
Ultrasound Market worth $13.87 billion in 2030 with 6.8% CAGR | MarketsandMarket …
Global ultrasound market valued at $8.65B in 2023, reached $9.32B in 2024, and is projected to grow at a robust 6.8% CAGR, hitting $13.87B by 2030.
The global Ultrasound Market [https://www.marketsandmarkets.com/Market-Reports/ultrasound-market-467.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=ultrasoundmarket], The global ultrasound market, valued at US$8.65 billion in 2023, is forecasted to grow at a robust CAGR of 6.8%, reaching US$9.32 billion in 2024 and an impressive US$13.87 billion by 2030. The ultrasound market is experiencing significant growth due…
Single-use Assemblies Market Size & Share - Global Future Growth Expectations
The single-use assemblies market is projected to reach USD 5.2 billion by 2028 from an estimated USD 2.5 billion in 2023, at a CAGR of 15.6% during the forecast period.
The global single-use assemblies market [https://www.marketsandmarkets.com/Market-Reports/single-use-assemblies-market-46226549.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=singleuseassembliesmarket], valued at US$ 2.52 billion in 2023, is forecasted to grow at a robust CAGR of 13.2%, reaching US$ 2.63 billion in 2024 and an impressive US$ 4.89 billion by 2029. The single-use assemblies market…
RNA Analysis Industry: Emerging Trends and Latest Innovations
In the world of biotechnology, RNA analysis has emerged as a critical field, shedding light on cellular processes and driving innovations in diagnostics and therapeutics. With the advent of advanced technologies and growing research investments, the RNA analysis industry is rapidly evolving.
In the near future, the RNA analysis industry is poised for unprecedented growth and innovation, driven by remarkable advancements in technology and research. With the increasing understanding of RNA's…
Autoinjectors Market to Hit USD 3.02 Bn by 2030: Growth Drivers, Key Players, an …
Asia Pacific market is estimated to grow at the highest CAGR of 15.7% during the forecast period.
The global autoinjectors market [https://www.marketsandmarkets.com/Market-Reports/autoinjector-market-173991724.html?utm_source=abnewswire.com&utm_medium=paidpr&utm_campaign=autoinjectormarket] is forecasted to grow from USD 1.40 billion in 2024 to USD 3.02 billion by 2030, driven by a robust CAGR of 13.6%. Similarly, the market for finished autoinjector formulations is expected to nearly double, reaching USD 134.27 billion by 2030 from USD 67.30 billion in 2024, growing at…
Monthly Wellness Capsules Market Is Booming Worldwide | Blackmores, Himalaya Wel …
HTF MI just released the Global Monthly Wellness Capsules Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in Monthly Wellness Capsules Market are:
Ritual (US), Care/of…
Nuclear Medicine Drugs Market Is Booming So Rapidly | Major Giants Siemens, Phil …
HTF MI just released the Global Nuclear Medicine Drugs Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2033. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Nuclear Medicine Drugs Market are:
Bayer, GE…
United States Ready Meals and Soup Market Worth US$ 82.8 Bn by 2032
The United States ready meals and soup market size was valued at US$ 64.9 billion in 2024 and is likely to reach USD 82.8 billion by 2032, expanding at a CAGR 3% during the forecast period.
United States Ready Meals and Soup Market Growth Drivers
The United States ready meals and soup market has seen significant growth in recent years. With busy lifestyles and increasing demand for convenience, more consumers are turning…
Exponential Growth Expected for Global Iron Chelation Drug Market With Complete …
The most recent in-depth analysis from Worldwide Market Reports offers a comprehensive global perspective on the evolving Global Iron Chelation Drug Market, equipping industry stakeholders with data-backed insights into shifting market dynamics, innovation cycles, and emerging business models. This report serves as a trusted roadmap for organizations navigating a landscape shaped by increasing competition, technological disruption, and fluctuating demand across geographies. From strategic positioning to investment trends, the study provides…
Unexpected Trends Reshaping the Global Oven Controlled Crystal Oscillator (OCXO) …
The latest comprehensive study on the Global Oven Controlled Crystal Oscillator (OCXO) Market by Worldwide Market Reports offers an in-depth exploration of industry dynamics, emerging trends, and market shifts that are shaping the future of global commerce. Crafted for a professional audience spanning the USA, UK, South Korea, and other key regions, this report delivers actionable intelligence to help organizations navigate uncertainty and seize new growth opportunities.
This robust research draws…
Exclusive Report on Global MBE Effusion Cells Industry: Market Size will Witness …
The latest report on the "Global Revenue for MBE Effusion Cells Market" by Worldwide Market Reports delivers a comprehensive and detailed evaluation of global industry dynamics, uncovering the core trends that shape the competitive landscape. By analyzing key growth drivers, market constraints, emerging opportunities, and sector challenges, the study offers an extensive understanding of the market's behavior. This report is based on rigorously validated research methodologies, ensuring data precision and…
Chemotherapy Induced Nausea and Vomiting Market Massive Growth opportunity Ahead
Introduction
Chemotherapy remains a cornerstone of cancer treatment, but it comes with a heavy burden of side effects. Among these, nausea and vomiting are among the most distressing, significantly impacting patient quality of life and adherence to therapy. Chemotherapy-induced nausea and vomiting (CINV) can lead to treatment discontinuation, malnutrition, and hospitalization if poorly managed, making effective supportive care a critical part of oncology practice.
Over the past decade, advances in serotonin (5-HT3)…
Cervix Lesion Market Outlook 2025-2034: Screening, Early Detection, and Advanced …
In 2024, the global cervix lesion market is valued at USD 2.9 billion and is projected to reach USD 6.1 billion by 2034, growing at a CAGR of 7.8% (2025-2034). The steady rise reflects the combined effect of heightened awareness, government-led prevention programs, and innovative diagnostic and therapeutic approaches.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71190
Market Overview: Key Highlights
Market Size (2024): USD 2.9 Billion
Forecasted Market Size (2034): USD…
c-MET Mutated Non-Small Cell Lung Cancer (NSCLC) Market Outlook 2025-2034: Preci …
In 2024, the global c-MET mutated NSCLC market is valued at USD 1.2 billion and is projected to reach USD 3.5 billion by 2034, growing at a CAGR of 11.4% (2025-2034). This strong trajectory reflects rising adoption of molecular testing, broader access to MET inhibitors, and robust clinical trial activity across regions.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71188
Market Overview: Key Highlights
Market Size (2024): USD 1.2 Billion
Forecasted Market…
Dry Eye Syndrome Treatment Market is Estimatd to Reach USD 11.0 Billion by 2034 …
Fact.MR today released its latest report on the Dry Eye Syndrome Treatment Market, projecting robust growth driven by rising prevalence of dry eye syndrome, increasing screen time, and advancements in treatment options. Valued at USD 4.0 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 7.2%, reaching USD 11.0 billion by 2034. This significant growth underscores the growing demand for effective…
Carcinoid Tumor Market Outlook 2025-2034: Expanding Diagnostics and Targeted The …
In 2024, the global carcinoid tumor market is estimated at USD 2.4 billion and is projected to reach USD 5.1 billion by 2034, growing at a CAGR of 7.6% (2025-2034).
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71186
Market Overview: Key Highlights
Market Size (2024): USD 2.4 Billion
Forecasted Market Size (2034): USD 5.1 Billion
CAGR (2025-2034): 7.6%
Largest Region (2024): North America (~45% share)
Fastest-Growing Region: Asia-Pacific (>9% CAGR)
Top Therapies: Somatostatin analogs (octreotide, lanreotide),…
Chronic Myelocytic Leukemia (CML) Market New Product Development & Latest Trends
Introduction
Chronic myelocytic leukemia (CML), also known as chronic myeloid leukemia, is a rare type of blood cancer characterized by the uncontrolled growth of abnormal white blood cells. It is strongly associated with the Philadelphia chromosome and the BCR-ABL fusion gene, which leads to continuous activation of tyrosine kinase signaling.
Over the past two decades, the approval of tyrosine kinase inhibitors (TKIs) revolutionized CML management, transforming it from a once-fatal condition into…
New experience reports: MUCOKEHL-D3 ointment in use against hemorrhoids
The author and publisher Markus Schall shares his personal experiences with the MUCOKEHL-D3 ointment from Sanum Kehlbeck for hemorrhoids on his blog. After more than six months of continuous use, he provides insights into his own therapeutic experiences, explains the advantages of this ointment over classic zinc preparations and explains why a holistic approach is crucial.
Gentle help for hemorrhoids: Personal first-hand experience
Markus Schall has been using MUCOKEHL-D3 ointment regularly for…
CAR-T Cell Therapy for Multiple Myeloma Market Outlook 2024-2034: Breakthrough C …
In 2024, the global CAR-T cell therapy for multiple myeloma market is valued at USD 3.1 billion and is projected to reach USD 15.4 billion by 2034, growing at a robust CAGR of 17.5% (2025-2034). This trajectory underscores CAR-T's growing role as a central pillar in multiple myeloma treatment.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71184
Market Overview: Key Highlights
Market Size (2024): USD 3.1 Billion
Forecasted Market Size (2034): USD…
Bruton's Tyrosine Kinase (BTK) Hematological Cancer Market Outlook 2024-2034: Ta …
In 2024, the global BTK hematological cancer market is valued at USD 8.7 billion and is projected to reach USD 21.5 billion by 2034, growing at a CAGR of 9.4% (2025-2034). This growth reflects increasing diagnosis rates, expanding clinical indications, and strong pipelines of next-generation BTK therapies.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71182
Market Overview: Key Highlights
Market Size (2024): USD 8.7 Billion
Forecasted Market Size (2034): USD 21.5 Billion
CAGR…
BRAF Mutant Metastatic Melanoma Market Outlook 2024-2034: Targeted Therapies and …
In 2024, the global BRAF mutant metastatic melanoma market is estimated at USD 1.6 billion. By 2034, it is projected to reach USD 3.9 billion, growing at a CAGR of 9.2% (2025-2034). This strong expansion reflects increasing mutation testing rates, broader use of targeted inhibitors, and rising adoption of combination immunotherapies across key regions.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71180
Market Overview: Key Highlights
Market Size (2024): USD 1.6…
The Conjugation and Labeling Services Market is projected to grow at a CAGR of 1 …
The complexities associated with conjugation of biomolecules and the need for click-chemistry expertise have prompted the pharmaceutical industry to rely on conjugation and labeling service providers
To request quote of this report, please visit:
https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market/request-quote.html
Roots Analysis is pleased to announce the publication of its recent study, titled, "Conjugation and Labeling Services Market, 2023-2035"
The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies.…
Basal Cell Neoplasms Market 2025-2034: Early Diagnosis, Minimally Invasive Care, …
In 2024, the Basal Cell Neoplasms market is valued at USD 5.0 billion and is projected to reach USD 9.5 billion by 2034, advancing at a 6.5% CAGR (2025-2034). North America currently leads the market, but Asia-Pacific is expected to record the fastest growth over the next decade.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71178
Market Overview: Key Highlights
Market Size (2024): USD 5.0 billion
Forecast (2034): USD 9.5 billion
CAGR (2025-2034):…
Continuous Patient Monitoring Systems Market Set to Surge by 2031
Driven by the rising incidence of chronic illnesses and ongoing technological innovation, healthcare delivery
New York, US - August 28, 2025 - The Insight Partners has published a new report titled "Continuous Patient Monitoring Systems Market Share, Size, Trends, and Forecast by 2031," projecting significant growth in the global market. The report underscores a steady rise in demand for continuous patient monitoring systems. According to the forecast, the market is expected…
Chronic Myeloid Leukemia (CML) Market Set to Witness Significant Growth by 2025- …
Introduction
Chronic myeloid leukemia (CML), a rare blood cancer caused by the BCR-ABL gene fusion, has undergone a therapeutic revolution over the last two decades. Once associated with poor survival rates, CML is now considered a largely manageable chronic condition, thanks to tyrosine kinase inhibitors (TKIs) such as imatinib, dasatinib, nilotinib, and ponatinib. These targeted therapies directly inhibit the abnormal kinase activity driving uncontrolled white blood cell proliferation, dramatically improving long-term…
NK Cell Therapy Market Outlook 2024-2034: Revolutionizing Cancer Immunotherapy
In 2024, the global NK cell therapy market is estimated at USD 2.1 billion. By 2034, it is projected to reach USD 12.8 billion, growing at an impressive CAGR of 20.1% (2025-2034). This rapid growth highlights the market's pivotal role in next-generation oncology and immunology treatment strategies.
Market Overview
The NK cell therapy market is characterized by strong clinical pipelines, biotech-pharma collaborations, and rising demand for targeted immunotherapies. Clinical progress in hematologic…
Neuroendocrine Tumors Market Outlook 2024-2034, Targeted Therapies Driving Stron …
In 2024, the global neuroendocrine tumors (NETs) market is valued at USD 4.6 billion. It is projected to reach USD 9.5 billion by 2034, growing at a CAGR of 7.3% (2025-2034). This growth is fueled by rising disease prevalence, advances in diagnostic technologies, and an expanding pipeline of innovative therapeutics, including somatostatin analogs, targeted radiotherapies, and immunotherapy agents.
This article provides a comprehensive overview of the NETs market, including segmentation, regional…
Cell Ovarian Cancer Market 2025-2034 Business Outlook, Critical Insight and Grow …
Introduction
Clear cell ovarian cancer (CCOC) is a molecularly distinct subtype of epithelial ovarian cancer with unique clinical behavior, therapy responses, and biomarker patterns. Though it accounts for a minority of overall ovarian cancer cases, its unmet needs are pronounced-particularly in platinum resistance, recurrence, and the management of disease in younger, often premenopausal, patients. As precision oncology matures, stakeholders across pharma, diagnostics, and care delivery are converging on targeted options (including…
Germ Cell Tumor Market Outlook 2024-2034: Innovation Driving Steady Growth
The global germ cell tumor market is evolving with major pharmaceutical companies, healthcare providers, and research institutions focusing on improved detection, tailored therapies, and survivorship programs.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71172
Market Size (2024): USD 1.9 Billion
Forecast (2034): USD 3.4 Billion
CAGR (2025-2034): 6.0%
Key Drivers: Growing incidence of germ cell tumors, increased access to advanced cancer diagnostics, and expanding use of immunotherapies.
Key Challenges: High treatment costs, delayed diagnosis…
Cutaneous Angiosarcoma Market New Product Development & Latest Trends
Introduction
Cutaneous angiosarcoma is a rare and aggressive malignancy that originates from endothelial cells lining blood vessels and lymphatics in the skin. Though it represents a small fraction of soft-tissue sarcomas, its high recurrence rates, metastatic potential, and poor prognosis make it one of the most challenging cancers to manage. The condition most frequently affects elderly patients and is often associated with chronic lymphedema, prior radiation exposure, or immunosuppression.
Traditional management has…
Indolent Lymphoma Market to Reach USD 17.2 Billion by 2034
Indolent lymphomas are a group of slow-growing non-Hodgkin's lymphomas (NHL) that include follicular lymphoma, marginal zone lymphoma, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma. While generally less aggressive than other forms of NHL, these cancers are often incurable and require long-term management strategies. Patients frequently undergo multiple lines of therapy over the course of their disease, making this a significant area of focus for pharmaceutical innovation.
The global indolent lymphoma market is…
HPV-Induced Cutaneous Tumors Market is expected to reach USD 2.5 billion by 2034
Human papillomavirus (HPV) is widely known for its role in cervical and other anogenital cancers, but it also causes a spectrum of cutaneous tumors, ranging from benign warts to malignant skin cancers in immunocompromised individuals. With increasing understanding of HPV's oncogenic potential and its impact on dermatological health, the HPV-induced cutaneous tumors market is attracting growing attention from pharmaceutical companies, dermatologists, and oncologists alike.
Download Full PDF Sample Copy of Market…
Jubilee Unveils Thrissur's First 384-Slice CT Scanner with New Radiodiagnosis Bl …
Thrissur, August 20, 2025: Jubilee Mission Medical College & Research Institute proudly inaugurated its new Radiodiagnosis Block, a state-of-the-art facility designed to enhance diagnostic excellence and patient care. The inauguration was led by Fr. Renny Mundenkurian, Director, Jubilee Mission, and the blessing ceremony was conducted by Fr. Jijo Maliyakkal.
At the heart of this new block is a major milestone for healthcare in Thrissur, the installation of the city's first 384-slice…
Go To Page 11238 11237 11236 11235 11234 11233 11232 11231 11230 11229 10198 10197 10196 10195 10194 10193 10192 10191 10190 10189